Literature DB >> 19251246

Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network.

Bin Wang1, Zhi-Bing You, Roy A Wise.   

Abstract

BACKGROUND: Hypocretin (Hcrt), an arousal- and feeding-associated peptide, is expressed in lateral hypothalamic neurons that project to the ventral tegmental area (VTA). Intra-VTA Hcrt reinstates morphine-conditioned place preferences, and intracerebroventricular and intra-VTA corticotropin-releasing factor (CRF) reinstate cocaine seeking. Each is presumed to act, at least in part, through actions local to the VTA. Here, we examined the possibility that VTA perfusion of Hcrt reinstates cocaine seeking and, if so, whether it does so through the VTA mechanism that is implicated in reinstatement by CRF.
METHODS: Rats were trained to lever-press for intravenous cocaine (2 weeks) and then underwent extinction training (saline substituted for cocaine: 3 weeks). Reinstatement behavior was tested and VTA dialysates were collected and assayed for glutamate or dopamine following footshock or perfusion of Hcrt or CRF, with or without Hcrt or CRF antagonists, into the VTA.
RESULTS: Ventral tegmental area perfusion of Hcrt-1 or footshock stress reinstated cocaine seeking and caused release of VTA glutamate and dopamine. The effects of Hcrt-1 were blocked by a selective Hcrt-1 antagonist, but not a CRF antagonist, and were not mimicked by Hcrt-2. The Hcrt-1 antagonist did not block CRF-dependent footshock-induced reinstatement or glutamate or dopamine release. The behavioral and neurochemical effects of Hcrt-1 were attenuated but not blocked by kynurenic acid, an ionotropic glutamate antagonist that blocks footshock-induced reinstatement and glutamate release.
CONCLUSIONS: While Hcrt and CRF are known to interact in some area of the brain, in the VTA proper they appear to have largely independent actions on the mesolimbic dopamine mechanisms of cocaine seeking.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251246      PMCID: PMC2705875          DOI: 10.1016/j.biopsych.2009.01.018

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  31 in total

1.  Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect.

Authors:  Minoru Narita; Yasuyuki Nagumo; Mayumi Miyatake; Daigo Ikegami; Kana Kurahashi; Tsutomu Suzuki
Journal:  Eur J Neurosci       Date:  2007-03       Impact factor: 3.386

Review 2.  Addiction and arousal: the hypocretin connection.

Authors:  Benjamin Boutrel; Luis de Lecea
Journal:  Physiol Behav       Date:  2007-11-22

3.  Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia.

Authors:  Hai-long Dong; Satoru Fukuda; Eri Murata; Zhenghua Zhu; Takashi Higuchi
Journal:  Anesthesiology       Date:  2006-05       Impact factor: 7.892

4.  Differential effect of orexins (hypocretins) on serotonin release in the dorsal and median raphe nuclei of freely behaving rats.

Authors:  R Tao; Z Ma; J T McKenna; M M Thakkar; S Winston; R E Strecker; R W McCarley
Journal:  Neuroscience       Date:  2006-07-03       Impact factor: 3.590

5.  Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate g protein subtypes in rat pontine reticular formation.

Authors:  René Bernard; Ralph Lydic; Helen A Baghdoyan
Journal:  J Pharmacol Exp Ther       Date:  2005-12-13       Impact factor: 4.030

6.  Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.

Authors:  Minoru Narita; Yasuyuki Nagumo; Seiko Hashimoto; Michiko Narita; Junaidi Khotib; Mayumi Miyatake; Takeshi Sakurai; Masashi Yanagisawa; Tomoya Nakamachi; Seiji Shioda; Tsutomu Suzuki
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

7.  Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area.

Authors:  Nicole M Vittoz; Craig W Berridge
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

8.  A role for conditioned ventral tegmental glutamate release in cocaine seeking.

Authors:  Zhi-Bing You; Bin Wang; Dawnya Zitzman; Soraya Azari; Roy A Wise
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

9.  Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons.

Authors:  Judith Joyce Balcita-Pedicino; Susan R Sesack
Journal:  J Comp Neurol       Date:  2007-08-10       Impact factor: 3.215

10.  Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat.

Authors:  Bin Wang; Zhi-Bing You; Kenner C Rice; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2007-04-17       Impact factor: 4.415

View more
  66 in total

1.  Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus.

Authors:  Jiann Wei Yeoh; Morgan H James; Phillip Jobling; Jaideep S Bains; Brett A Graham; Christopher V Dayas
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

Review 2.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

3.  Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement.

Authors:  James R Shoblock; Natalie Welty; Leah Aluisio; Ian Fraser; S Timothy Motley; Kirsten Morton; James Palmer; Pascal Bonaventure; Nicholas I Carruthers; Timothy W Lovenberg; Jamin Boggs; Ruggero Galici
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

4.  Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus.

Authors:  Irene Morganstern; Guo-Q Chang; Jessica R Barson; Zhiyu Ye; Olga Karatayev; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2010-03-10       Impact factor: 3.455

5.  Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors.

Authors:  B Jupp; E Krstew; G Dezsi; A J Lawrence
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

6.  Hypocretin/orexin antagonists decrease cocaine self-administration by female rhesus monkeys.

Authors:  Richard W Foltin; Suzette M Evans
Journal:  Drug Alcohol Depend       Date:  2018-05-25       Impact factor: 4.492

Review 7.  Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.

Authors:  Uri Shalev; Suzanne Erb; Yavin Shaham
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

Review 8.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

Review 9.  Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms.

Authors:  Mitchell R Farrell; Hannah Schoch; Stephen V Mahler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-01-03       Impact factor: 5.067

10.  Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.